Trade Desk faces uncertainty in post-pandemic advertising market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Westlake Village BioPartners makes big bet on gene therapy with Capsida
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Interlink shares drop after report of first-quarter losses
Interlink Electronics, an Irvine-based sensor manufacturer with its primary research and development facility in Camarillo, saw its revenue dip and its net loss increase when it released its earnings for the first quarter of 2021. According to the company’s May 6 earnings release, Interlink generated revenue of $1.56 million in the first quarter of 2021, Read More →
MIT to drop affiliation with Central Coast Enterprise Forum
The Massachusetts Institute of Technology Enterprise Forum Global will be closing its program effective June 30 and is asking all of its affiliated chapters, including the Central Coast chapter, to discontinue all association with the brand. The news came in an April 30 email to Enterprise Forum chapters from the CEO of MIT Technology Review, Read More →
H-1B freeze lifted, but most foreign workers still locked out
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
With dozens of hires per week, Meissner Filtration is booming
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks biotech firm closes $140M funding round
Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →
